For columnist Caroline Gainer, treatment for chronic obstructive pulmonary disease isn't always found in the operating room.

The first COPD patient has been dosed in a Phase 1b COPD trial testing Bambusa Therapeutics’ dual-target therapy BBT002.

Columnist Caroline Gainer remembers a horseback ride that taught her a lesson about how to respond when you find yourself ...

Mabwell’s experimental therapy 9MW1911 may reduce the frequency of moderate to severe exacerbations in people with chronic obstructive pulmonary disease (COPD), according to data from a completed ...

After a challenging period of illness that included shingles, diverticulitis, and a respiratory infection, I found myself profoundly weakened. My muscles had softened, my breath felt shallow, and even ...

The American Lung Association Research Institute is investing $22 million to advance research and support care for lung disease, including chronic obstructive pulmonary disease (COPD). “Research is ...

I will soon be 82, and my weight has been an issue since being diagnosed with chronic obstructive pulmonary disease (COPD). For most of my adult life, I weighed 113 pounds and was 5 feet, 1 inch tall.

I’ve recently been reflecting on how Maslow’s hierarchy of needs intersects with chronic illness, moderate means, and the dignity of helping others. I’m doing so through the lens of my chronic ...

While watching coverage of a landslide on my news feed, I was reminded of a time when I had a close brush with one. A carpool I was in just missed it, but the carpool of friends behind us wasn’t so ...

Genentech has announced mixed top-line results from two global clinical trials testing its treatment candidate astegolimab in people with moderate to very severe chronic obstructive pulmonary disease ...

Caroline Gainer is from West Virginia, the state with the highest rate of COPD in the United States. She was diagnosed with moderate-to-severe COPD in 2013 after a pneumothorax (lung collapse). After ...

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain people with chronic obstructive pulmonary disease (COPD). The treatment, ...